Caesars Entertainment misses Q2 earnings expectations, shares edge lower
American Vanguard Corp . (NYSE:AVD), currently trading at $4.94 with a market capitalization of $142.45 million, has announced that it regained compliance with the New York Stock Exchange (NYSE) listing standards. This follows a previous notice of noncompliance due to a delay in filing its annual report for the fiscal year ending December 31, 2024. The company resolved the issue by submitting the required Form 10-K and its Form 10-Q for the quarter ending March 31, 2025.
The NYSE had initially notified American Vanguard on April 2, 2025, about the noncompliance with Section 802.01E of the NYSE Listed Company Manual. The company received written confirmation of compliance from NYSE Regulation on June 6, 2025, closing the matter. While the company faced challenges in the last twelve months, InvestingPro analysis indicates strong potential ahead, with analysts forecasting a return to profitability this year.
Additionally, American Vanguard held an earnings call on June 6, 2025, to discuss its unaudited financial results for the first quarter of the year. A transcript of this call has been made available as part of the company’s SEC filing.
This information is based on an 8-K filing with the Securities and Exchange Commission, detailing the company’s compliance status and financial disclosures.
In other recent news, American Vanguard Corporation reported a 14% decline in net sales for Q1 2025 compared to the same period last year, bringing in $116 million in revenue. The company’s adjusted EBITDA also fell sharply to $3 million from $15.5 million in the previous year. Despite these financial setbacks, American Vanguard managed to reduce its debt by approximately 14% and cut operating expenses by $5 million. The company revised its full-year adjusted EBITDA guidance to a range of $40-44 million, down from the previous estimate of $45-52 million, with revenue projections set between $535-545 million. Analysts from Lake Street Capital noted the impact of the removal of the Dactol product, which led to a $6 million hit in sales. CEO Dak Kay emphasized ongoing efforts to improve cost structures and streamline the balance sheet, while CFO David Johnson mentioned that the company is exploring options to replace its current credit agreement. Despite the challenges, American Vanguard anticipates a stronger performance in the latter half of 2025, with growth in 2026 expected to surpass the industry average.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.